Vantage Consulting Group’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-252
Closed -$13K 791
2020
Q4
$13K Buy
+252
New +$13.2K ﹤0.01% 1071

Other funds holding IHI

Vantage Consulting Group's IHI Position: Q1 2021 in Review

Vantage Consulting Group sold out of iShares US Medical Devices ETF (IHI) in Q1 2021, closing a stake of 252 shares — an estimated $13K sold.

Vantage Consulting Group first reported a position in IHI in Q4 2020 and held it in 1 quarter. The position peaked at $13K in Q4 2020. 566 funds tracked by Wall St. Rank hold IHI as of Q1 2021.

  • Vantage Consulting Group reported no remaining iShares US Medical Devices ETF position as of Q1 2021 after selling out during the quarter.
  • Vantage Consulting Group sold 252 iShares US Medical Devices ETF shares in Q1 2021, an estimated $13K.
  • Vantage Consulting Group first reported a position in iShares US Medical Devices ETF in Q4 2020 and held it in 1 quarter.
  • Vantage Consulting Group's iShares US Medical Devices ETF position peaked at $13K in Q4 2020.
  • 566 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.